Dr. David Bernstein, vice chair of the AAAAI committee on immunotherapy, warns that undergoing immunotherapy is a long-term commitment. “However, it is still the best treatment available to control and prevent symptoms or to reduce a need for daily medications. Read the rest of this entry »